Key Market
Life Sciences
The changing life sciences landscape: engineering solutions for a healthier world

In a constantly evolving industry where novel viruses emerge and new treatments evolve where security of supply, shifting production modes, sustainability and safety challenges, and aging infrastructure are a concern, the life science and pharmaceutical industry are constantly innovating in an extremely competitive sector – they need a partner that parallels their aspirations and unlocks bespoke solutions to their build environment needs.

Wood is engineering solutions for a healthier world by partnering with global pharmaceutical, biotechnology, healthcare and research organisations providing expertise across the full asset life cycle.

Related Insights
  • Blog

    Delivering the resilient infrastructure essential for improving human health

  • Blog

    At the forefront of the fight against infectious diseases in Australia

  • Blog

    Inspection of the Future: Connected Integrity

Connect with our experts
Angelo Bernardis
Life-Science Global Technology Lead
Robert Forbes
Director of Architecture, Life Sciences
Marco Bolognini
VP, Business Development Life Sciences Sector
Frederic Jeunet
Vice President Life Sciences Australia
Kenneth L. Bibbo
Director, Emerging Technologies
Jim Goff
Senior Vice President of Life Sciences
Christina Meyer Dell Cioppia
Vice President, CQV
Deb Marsh
Director of Business Development
  • Press release
    Wood appoints new leader to accelerate growth in Life Sciences
    Wood appoints Jim Goff as Senior Vice President of Life Sciences as the company accelerates its growth ambitions in US life sciences, pharmaceutical, biopharmaceutical and biotechnology markets.
  • Case study
    Ensuring resilient ecosystems and healthy marine habitats for two of the world’s biggest seaports
    California’s San Pedro Bay is home to two of the world’s busiest container ports, the Port of Los Angeles and the Port of Long Beach. Together, sitting side-by-side as the San Pedro Bay Port Complex, they are critical links in the United States’ supply chain. Yet, international trade isn’t their only focus.
  • Case study
    A world-class pharma facility for Saudi Arabia’s future
    When Pfizer needed a new manufacturing facility for the production and packaging of pharmaceuticals in Saudi Arabia, we partnered together with our client to provide a wide range of multidisciplinary services
  • Case study
    High containment lab design
    Case study of designing and delivering world-class high containment laboratories and infectious diseases units in Australia
Related News
  • Press release

    Wood expands UK pharma footprint with GlaxoSmithKline contract win

  • Wood wins contracts for Teva Biotech facility in Germany